Navigation Links
Genetic signature identified for RSV, the leading cause of infant hospitalizations worldwide
Date:11/14/2013

esponds to RSV, information vital to the development of a vaccine, says Octavio Ramilo, MD, a co-lead author of the study and chief of the Section of Infectious Diseases at Nationwide Children's.

"We urgently need better treatments for this disease and eventually a vaccine that can prevent RSV infection," says Dr. Ramilo, who also is a professor of pediatrics at The Ohio State University College of Medicine.

Dr. Ramilo is one of many scientists in the Center for Vaccines and Immunity who have spent decades trying to unravel the biological underpinnings of RSV, a virus that remains largely unknown to the general public. Despite its anonymity, RSV leads to one-quarter of all hospitalizations for pneumonia and 70 percent of hospitalizations for bronchiolitis in young children. RSV also causes severe pneumonia in immunocompromised patients and the elderly.

"We need to do a better job educating our patients and their families about RSV and the huge morbidity associated with these infections," he says.


'/>"/>

Contact: Gina Bericchia
Gina.Bericchia@NationwideChildrens.org
614-355-0495
Nationwide Children's Hospital
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Nurture impacts nature: Experiences leave genetic mark on brain, behavior
2. Cause of genetic disorder found in dark matter of DNA
3. Genetic variation increases risk of kidney disease progression in African-Americans
4. Genetic aberration paves the way for new treatment of cancer disease
5. Genetic study proves Israels wild boars originated in Europe
6. Dolphin genetic study provides revelations
7. Genetic rarity rules in wild guppy population, study finds
8. GenSeq: Updated nomenclature for genetic sequences to solve taxonomic determination issues
9. BUSM researchers study epigenetic mechanisms of tumor metastasis for improved cancer therapy
10. HIV -- Geneticists map human resistance to AIDS
11. Measuring segments of genetic material may help predict and monitor recurrence after thyroid cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... a multitude of cells types. Researchers would like to understand ... mature cells that make up the organs and other structures ... long chains of sugars that dangle from proteins on surfaces ... California, San Diego, has created synthetic molecules that can stand ... manipulated to direct the process, they report in the ...
(Date:7/29/2014)... by academics in the University of Bristol,s Nutrition and ... liquid calories into account when planning meals. , The ... Study of Ingestive Behavior Conference (SSIB 2014) in Seattle, ... that we do. , The team was led by ... of Experimental Psychology. , As part of a Biotechnology ...
(Date:7/29/2014)... 2014 Research and Markets  has announced ... (BI) Market 2014-2018" report to their offering. ... The term BI refers to applications and technologies that ... information about a company,s operations. BI help organizations to ... for example, metrics on sales, production, and internal operations. ...
Breaking Biology News(10 mins):Global SaaS-based Business Intelligence (BI) Market 2014-2018 2
... increase in the number of infections with a specific ... Salmonella serovar Typhimurium DT104, is resistant to at least ... genetic information in DNA of DT104 that might be ... information might also be involved in the increase in ...
... clinical trials, coronary artery bypass surgery performed on a beating ... safe option that leads to fewer negative side effects for ... Surgery. , “Previously, it was more common for doctors ... the heart and passing the blood through a heart-lung machine,?says ...
... key enzyme can soothe over-excited receptors in the brain, ... Alzheimer's and other neurodegenerative diseases. , Lead author Michel ... student Wei Xu and collaborators from the University of ... issue of Neuron. , The researchers injected ...
Cached Biology News:Salmonella survives better in stomach due to altered DNA 2Decoy pill saves brain cells 2
(Date:7/30/2014)... JUPITER, Fla. , July 30, 2014 /PRNewswire/ ... global biotechnology company whose patented and proprietary technologies ... enzymes and other proteins for the bioenergy, bio-based ... the appointment of Thomas "Tom" Dubinski as Vice ... responsible for leading the financial and information technology ...
(Date:7/30/2014)... July 30, 2014  RXi Pharmaceuticals Corporation ... company focused on discovering, developing and commercializing ... using RNA-targeted technologies, today announced that their ... for the reduction of recurrence of hypertrophic ... been initiated. Logo - ...
(Date:7/30/2014)... CA (PRWEB) July 30, 2014 Adding ... their weighing boat special – Buy 2 ... free. This promotion will benefit lab technicians looking for ... Weighing boats are ideal for multiple applications including weighing ... a variety of choices including diamond-shaped, hexagonal, square, aluminum ...
(Date:7/29/2014)... 2014 “PharmaSphere: Emerging Biotech Investment ... Capital Funding” report provides in-depth analysis of the ... and venture capital segments of the financial industry, ... have significant impact on the future of emerging ... the report identifies regions of the world that ...
Breaking Biology Technology:Thomas Dubinski joins Dyadic as Chief Financial Officer 2Thomas Dubinski joins Dyadic as Chief Financial Officer 3Thomas Dubinski joins Dyadic as Chief Financial Officer 4RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 2RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 3RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 4RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 5Weighing Boat Promotion Now Available at Pipette.com, Major Pipette Distributor 2Strategic Trends of Biotech Investment Industry (Private Equity and Venture Capital Funding) in New Report Available at MarketOptimizer.org 2Strategic Trends of Biotech Investment Industry (Private Equity and Venture Capital Funding) in New Report Available at MarketOptimizer.org 3Strategic Trends of Biotech Investment Industry (Private Equity and Venture Capital Funding) in New Report Available at MarketOptimizer.org 4
... science and public policy with the needs of consumers ... any chance of reducing the effects of carbon on ... of the American Association for the Advancement of Science ... the global energy system, says Mike Davis, who leads ...
... morally acceptable? , For a significant percentage of Americans, ... of Americans, attitudes about the science of the very ... at the annual meeting of the American Association for ... Wisconsin-Madison professor of life sciences communication, presented new survey ...
... Therapies that Significantly Raises HDL "Good" Cholesterol and ... ... ABBOTT PARK, Ill., Feb. 15 Today, Abbott,received U.S. Food ... two widely prescribed cholesterol,therapies, Niaspan(R) (Abbott,s proprietary niacin extended-release) and,simvastatin. SIMCOR ...
Cached Biology Technology:Mission critical for carbon management 2Mission critical for carbon management 3Religion colors Americans' views of nanotechnology 2Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management 2Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management 3Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management 4Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management 5Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management 6
Request Info...
Immunogen: Recombinant full length protein. Storage: -20 C, Avoid Freeze/Thaw Cycles...
...
... Immunogen: Synthetic peptide derived from the ... bovine Math-2. Specificity: Specific for ... Rat (positive controls: human U251 A172 ... and rat brain homogenates)Storage: Store at ...
Biology Products: